Seeking Novel Leads in Rare Diseases and Neuroscience

Ipsen, a global biopharmaceutical company, is seeking novel and innovative leads to treat rare disease and rare neuroscience disease indications. A range of therapeutic areas and targets will be considered, but target diseases should be rare (>1.5 per million, <1 per 2,000).

A range of mechanisms‑of‑action and classes of molecules are of interest, with a particular focus on small molecules, peptides, biologics, nucleic acids, RNA therapies (i.e. siRNAs) and antibody conjugates. Ipsen is open to a variety of drug delivery methods.

Development Stage of Interest...